EDITORIAL
Published on 06 Jul 2023
Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases
doi 10.3389/fgeed.2023.1248904
- 1,799 views
- 1 citation
- Frontiers in Genome Editing
- Genome Editing in Human Health and Disease
- Research Topics
- Ex-Vivo and In-Vivo Genome Engineering for Metabolic and Neurometabolic Diseases
Ex-Vivo and In-Vivo Genome Engineering for Metabolic and Neurometabolic Diseases
8,298
Total downloads
30k
Total views and downloads
Articles
REVIEW
Published on 09 Jan 2023
Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders
doi 10.3389/fgeed.2022.997142
- 5,615 views
- 7 citations
REVIEW
Published on 17 May 2022
Advantages and Limitations of Gene Therapy and Gene Editing for Friedreich’s Ataxia
doi 10.3389/fgeed.2022.903139
- 9,166 views
- 20 citations
ORIGINAL RESEARCH
Published on 11 Mar 2022
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice
doi 10.3389/fgeed.2022.785698
- 4,243 views
- 16 citations
MINI REVIEW
Published on 25 Nov 2021
Prime Editing for Inherited Retinal Diseases
doi 10.3389/fgeed.2021.775330
- 6,880 views
- 23 citations
